<?xml version='1.0' encoding='utf-8'?>
<document id="15116058"><sentence text="The effect of gemfibrozil on the pharmacokinetics of rosuvastatin."><entity charOffset="14-25" id="DDI-PubMed.15116058.s1.e0" text="gemfibrozil" /><entity charOffset="53-65" id="DDI-PubMed.15116058.s1.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.15116058.s1.e0" e2="DDI-PubMed.15116058.s1.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s1.e0" e2="DDI-PubMed.15116058.s1.e1" /></sentence><sentence text="Coadministration of statins and gemfibrozil is associated with an increased risk for myopathy, which may be due in part to a pharmacokinetic interaction"><entity charOffset="32-43" id="DDI-PubMed.15116058.s2.e0" text="gemfibrozil" /></sentence><sentence text=" Therefore the effect of gemfibrozil on rosuvastatin pharmacokinetics was assessed in healthy volunteers"><entity charOffset="25-36" id="DDI-PubMed.15116058.s3.e0" text="gemfibrozil" /><entity charOffset="40-52" id="DDI-PubMed.15116058.s3.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.15116058.s3.e0" e2="DDI-PubMed.15116058.s3.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s3.e0" e2="DDI-PubMed.15116058.s3.e1" /></sentence><sentence text=" Rosuvastatin has been shown to be a substrate for the human hepatic uptake transporter organic anion transporter 2 (OATP2)"><entity charOffset="1-13" id="DDI-PubMed.15116058.s4.e0" text="Rosuvastatin" /></sentence><sentence text=" Inhibition of this transporter could increase plasma concentrations of rosuvastatin"><entity charOffset="72-84" id="DDI-PubMed.15116058.s5.e0" text="rosuvastatin" /></sentence><sentence text=" The effect of gemfibrozil on rosuvastatin uptake by cells expressing OATP2 was also examined"><entity charOffset="15-26" id="DDI-PubMed.15116058.s6.e0" text="gemfibrozil" /><entity charOffset="30-42" id="DDI-PubMed.15116058.s6.e1" text="rosuvastatin" /><entity charOffset="70-75" id="DDI-PubMed.15116058.s6.e2" text="OATP2" /><pair ddi="false" e1="DDI-PubMed.15116058.s6.e0" e2="DDI-PubMed.15116058.s6.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s6.e0" e2="DDI-PubMed.15116058.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s6.e0" e2="DDI-PubMed.15116058.s6.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s6.e1" e2="DDI-PubMed.15116058.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s6.e1" e2="DDI-PubMed.15116058.s6.e2" /></sentence><sentence text="" /><sentence text="In a randomized, double-blind, 2-period crossover trial, 20 healthy volunteers were given oral doses of gemfibrozil, 600 mg, or placebo twice daily for 7 days"><entity charOffset="104-115" id="DDI-PubMed.15116058.s8.e0" text="gemfibrozil" /></sentence><sentence text=" On the fourth morning of each dosing period, a single oral dose of rosuvastatin, 80 mg, was coadministered"><entity charOffset="68-80" id="DDI-PubMed.15116058.s9.e0" text="rosuvastatin" /></sentence><sentence text=" Plasma concentrations of rosuvastatin, N-desmethyl rosuvastatin, and rosuvastatin-lactone were measured"><entity charOffset="26-38" id="DDI-PubMed.15116058.s10.e0" text="rosuvastatin" /><entity charOffset="40-64" id="DDI-PubMed.15116058.s10.e1" text="N-desmethyl rosuvastatin" /><entity charOffset="70-90" id="DDI-PubMed.15116058.s10.e2" text="rosuvastatin-lactone" /><pair ddi="false" e1="DDI-PubMed.15116058.s10.e0" e2="DDI-PubMed.15116058.s10.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s10.e0" e2="DDI-PubMed.15116058.s10.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s10.e0" e2="DDI-PubMed.15116058.s10.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s10.e1" e2="DDI-PubMed.15116058.s10.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s10.e1" e2="DDI-PubMed.15116058.s10.e2" /></sentence><sentence text=" In addition, the effect of gemfibrozil on the uptake of radiolabeled rosuvastatin by OATP2-transfected Xenopus oocytes was studied"><entity charOffset="28-39" id="DDI-PubMed.15116058.s11.e0" text="gemfibrozil" /><entity charOffset="70-82" id="DDI-PubMed.15116058.s11.e1" text="rosuvastatin" /><entity charOffset="86-97" id="DDI-PubMed.15116058.s11.e2" text="OATP2" /><pair ddi="false" e1="DDI-PubMed.15116058.s11.e0" e2="DDI-PubMed.15116058.s11.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s11.e0" e2="DDI-PubMed.15116058.s11.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s11.e0" e2="DDI-PubMed.15116058.s11.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s11.e1" e2="DDI-PubMed.15116058.s11.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s11.e1" e2="DDI-PubMed.15116058.s11.e2" /></sentence><sentence text="" /><sentence text="Gemfibrozil increased the rosuvastatin area under the plasma concentration-time curve from time 0 to the time of the last quantifiable concentration [AUC(0-t)] 1"><entity charOffset="0-11" id="DDI-PubMed.15116058.s13.e0" text="Gemfibrozil" /><entity charOffset="26-38" id="DDI-PubMed.15116058.s13.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.15116058.s13.e0" e2="DDI-PubMed.15116058.s13.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s13.e0" e2="DDI-PubMed.15116058.s13.e1" /></sentence><sentence text="88-fold (90% confidence interval, 1" /><sentence text="60-2" /><sentence text="21) and the maximum observed rosuvastatin plasma concentration (C(max)) 2"><entity charOffset="29-41" id="DDI-PubMed.15116058.s16.e0" text="rosuvastatin" /></sentence><sentence text="21-fold (90% confidence interval, 1" /><sentence text="81-2" /><sentence text="69) compared with placebo" /><sentence text=" N-desmethyl rosuvastatin AUC(0-t) and C(max) decreased by 48% and 39%, respectively"><entity charOffset="1-34" id="DDI-PubMed.15116058.s20.e0" text="N-desmethyl rosuvastatin AUC(0-t)" /></sentence><sentence text=" Pharmacokinetics of rosuvastatin-lactone was unchanged"><entity charOffset="21-41" id="DDI-PubMed.15116058.s21.e0" text="rosuvastatin-lactone" /></sentence><sentence text=" The in vitro results indicate that the maximum gemfibrozil inhibition of rosuvastatin OATP2-mediated uptake was 50%; the inhibition constant for the inhibitory process was 4"><entity charOffset="87-106" id="DDI-PubMed.15116058.s22.e0" text="OATP2" /></sentence><sentence text="0 +/- 1" /><sentence text="3 micromol/L" /><sentence text="" /><sentence text="Gemfibrozil increased rosuvastatin plasma concentrations approximately 2-fold, which is similar to the effect of gemfibrozil on pravastatin, simvastatin acid, and lovastatin acid plasma concentrations and substantially less than the effect observed for cerivastatin"><entity charOffset="0-11" id="DDI-PubMed.15116058.s26.e0" text="Gemfibrozil" /><entity charOffset="22-34" id="DDI-PubMed.15116058.s26.e1" text="rosuvastatin" /><entity charOffset="113-124" id="DDI-PubMed.15116058.s26.e2" text="gemfibrozil" /><entity charOffset="128-139" id="DDI-PubMed.15116058.s26.e3" text="pravastatin" /><entity charOffset="141-157" id="DDI-PubMed.15116058.s26.e4" text="simvastatin acid" /><entity charOffset="163-178" id="DDI-PubMed.15116058.s26.e5" text="lovastatin acid" /><entity charOffset="253-265" id="DDI-PubMed.15116058.s26.e6" text="cerivastatin" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e3" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e4" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e0" e2="DDI-PubMed.15116058.s26.e6" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e3" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e4" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e1" e2="DDI-PubMed.15116058.s26.e6" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e2" e2="DDI-PubMed.15116058.s26.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e2" e2="DDI-PubMed.15116058.s26.e3" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e2" e2="DDI-PubMed.15116058.s26.e4" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e2" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e2" e2="DDI-PubMed.15116058.s26.e6" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e3" e2="DDI-PubMed.15116058.s26.e3" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e3" e2="DDI-PubMed.15116058.s26.e4" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e3" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e3" e2="DDI-PubMed.15116058.s26.e6" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e4" e2="DDI-PubMed.15116058.s26.e4" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e4" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e4" e2="DDI-PubMed.15116058.s26.e6" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e5" e2="DDI-PubMed.15116058.s26.e5" /><pair ddi="false" e1="DDI-PubMed.15116058.s26.e5" e2="DDI-PubMed.15116058.s26.e6" /></sentence><sentence text=" Gemfibrozil inhibition of OATP2-mediated rosuvastatin hepatic uptake may contribute to the mechanism of the drug-drug interaction"><entity charOffset="1-12" id="DDI-PubMed.15116058.s27.e0" text="Gemfibrozil" /><entity charOffset="42-54" id="DDI-PubMed.15116058.s27.e1" text="rosuvastatin" /><entity charOffset="27-38" id="DDI-PubMed.15116058.s27.e2" text="OATP2" /><pair ddi="false" e1="DDI-PubMed.15116058.s27.e0" e2="DDI-PubMed.15116058.s27.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s27.e0" e2="DDI-PubMed.15116058.s27.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s27.e0" e2="DDI-PubMed.15116058.s27.e1" /><pair ddi="false" e1="DDI-PubMed.15116058.s27.e2" e2="DDI-PubMed.15116058.s27.e2" /><pair ddi="false" e1="DDI-PubMed.15116058.s27.e2" e2="DDI-PubMed.15116058.s27.e1" /></sentence><sentence text=" Care is warranted when gemfibrozil is coadministered with rosuvastatin and other statins"><entity charOffset="24-35" id="DDI-PubMed.15116058.s28.e0" text="gemfibrozil" /><entity charOffset="59-71" id="DDI-PubMed.15116058.s28.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.15116058.s28.e0" e2="DDI-PubMed.15116058.s28.e0" /><pair ddi="false" e1="DDI-PubMed.15116058.s28.e0" e2="DDI-PubMed.15116058.s28.e1" /></sentence><sentence text="" /></document>